{"gene":"CYB5A","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2010,"finding":"CYB5A is required for androstenedione production in human adrenal cells: siRNA knockdown of CYB5A in H295R adrenal cells significantly inhibited androstenedione production, and co-expression of CYB5A with HSD3B2 was identified at the ZF/ZR border as the cellular basis for adrenal androstenedione synthesis.","method":"siRNA knockdown in H295R cells with androstenedione measurement; co-immunolocalization of HSD3B2 and CYB5A in human adrenal tissue","journal":"The Journal of steroid biochemistry and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean siRNA knockdown with defined steroid phenotype plus orthogonal immunolocalization, single lab","pmids":["21185375"],"is_preprint":false},{"year":2015,"finding":"A CYB5A intronic SNP (rs1790834) doubles CYB5A mRNA expression and results in 2–3-fold activation of steroid 17,20-lyase activity, establishing CYB5A as a critical cofactor that augments CYP17A1 17,20-lyase activity in human steroidogenesis.","method":"Radiolabeled steroid conversion assay in synovial fibroblasts; quantitative RT-PCR; immunohistochemistry of synovial tissue","journal":"Arthritis research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional steroid conversion assay with radiolabeled substrate plus mRNA quantification, single lab","pmids":["25890314"],"is_preprint":false},{"year":2005,"finding":"A SNP in the 5' UTR of porcine CYB5A (G→T at position −8 of ATG) reduces CYB5A enzymatic activity and is associated with lower fat androstenone levels, demonstrating that CYB5A activity directly drives 16-androstene (androstenone) biosynthesis.","method":"Functional analysis of CYB5A enzyme activity in individuals of different genotypes; androstenone measurement in 229 testis samples","journal":"Mammalian genome","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct enzyme activity measurement linked to genotype with large sample size, single lab","pmids":["16104384"],"is_preprint":false},{"year":2019,"finding":"Specific surface residues of porcine CYB5A mediate its physical interaction with CYP17A1 to stimulate 17,20-lyase and delta-16-synthase reactions: mutations at CYB5A surface residues (including N62S, N21K, L28V, R52M) altered production of DHEA and 16-androstene (16A) from pregnenolone, and the N62S mutation increased both 16A and DHEA production when combined with wild-type CYP17A1.","method":"Site-directed mutagenesis of CYB5A and CYP17A1; co-expression with POR and CYB5R3 in HEK293 cells; radiolabeled pregnenolone conversion measured by HPLC","journal":"The Journal of steroid biochemistry and molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in cell-based system with mutagenesis and quantitative metabolite profiling; multiple residues tested with orthogonal outcomes","pmids":["31509771"],"is_preprint":false},{"year":2024,"finding":"CYB5A and mitochondrial CYB5B redundantly support sterol C4-demethylation in cholesterol biosynthesis: knockout of CYB5B alone blocks cholesterol biosynthesis at the sterol-C4 oxidation step in HeLa cells (accumulating T-MAS and dihydro-T-MAS), whereas liver-specific Cyb5b knockout mice are rescued by residual Cyb5a; combined knockdown of both in liver causes marked T-MAS/dihydro-T-MAS accumulation, demonstrating that either CYB5A or CYB5B is sufficient for sterol C4-demethylation.","method":"CRISPR knockout of CYB5B in HeLa cells; liver-specific Cyb5b knockout mice with shRNA knockdown of Cyb5a; sterol profiling; SREBP/PPARγ pathway analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro and in vivo knockouts with defined sterol metabolite readouts, multiple genetic combinations, orthogonal pathway analyses","pmids":["39489939"],"is_preprint":false},{"year":2019,"finding":"Loss-of-function mutations in CYB5A cause isolated 17,20-lyase deficiency in humans: a homozygous nonsense mutation (p.Tyr35Ter) in CYB5A results in methemoglobinemia and biochemically confirmed isolated 17,20-lyase deficiency, demonstrating that CYB5A is required for CYP17A1 17,20-lyase activity in vivo.","method":"Clinical case with genetic sequencing; hormonal studies confirming isolated 17,20-lyase deficiency; methemoglobin measurement","journal":"Journal of the Endocrine Society","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human loss-of-function variant with defined biochemical phenotype; single case but consistent with genetic mechanism","pmids":["32051920"],"is_preprint":false},{"year":2021,"finding":"Steroid metabolomics in patients with novel CYB5A loss-of-function variants reveals that CYB5A is required for DHEA synthesis postnatally but that neonatal DHEAS production is less dependent on CYB5A, and that a separate lyase activity independent of CYB5A handles cortisol side-chain cleavage.","method":"Urine steroid metabolomics (mass spectrometry) across age groups in CYB5A-deficient patients; gonadotropin stimulation testing","journal":"Hormone research in paediatrics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human loss-of-function with quantitative steroid metabolomics, multiple time points, but small case series","pmids":["33626548"],"is_preprint":false},{"year":2014,"finding":"CYB5A inhibits oncogenic phenotypes in pancreatic cancer cells through induction of autophagy, and its inhibitory activity involves downstream pathways including TRAF6.","method":"In vitro and in vivo studies (loss-of-function) with autophagy readouts; pathway analysis involving TRAF6","journal":"Autophagy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — abstract describes in vitro/in vivo results but provides limited methodological detail; single lab, no orthogonal mechanistic validation described","pmids":["24448000"],"is_preprint":false},{"year":2025,"finding":"CYB5A promotes osteogenic differentiation of MC3T3-E1 cells by stimulating autophagy through the AKT/mTOR/ULK1 signaling pathway: CYB5A overexpression increased LC3-II/LC3-I ratio, decreased P62, activated ULK1, and reduced mTOR phosphorylation; autophagy inhibitors and activators confirmed pathway mediation.","method":"Overexpression and siRNA knockdown in MC3T3-E1 cells; Western blotting for LC3-II/LC3-I, P62, phospho-mTOR, ULK1; autophagy inhibitor/activator pharmacological validation","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with multiple pathway readouts and pharmacological confirmation, single lab","pmids":["40246926"],"is_preprint":false},{"year":2014,"finding":"SNPs in the porcine CYB5A promoter region affect transcription factor binding and CYB5A expression levels: haplotype B (containing specific SNPs) showed higher reporter activity in cell transfection assays, and EMSA demonstrated that the SNP at position 165901767 affects stable binding of transcription factors (including predicted MAZ binding site) to the CYB5A promoter, translating into differential androstenone accumulation between Chinese and European pig breeds.","method":"Luciferase reporter assay; electrophoretic mobility shift assay (EMSA); quantitative PCR of liver tissues; in silico transcription factor prediction","journal":"Animal genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter assay with orthogonal in vivo expression data, single lab","pmids":["25516134"],"is_preprint":false}],"current_model":"CYB5A encodes microsomal cytochrome b5, a hemoprotein electron transfer cofactor that directly augments CYP17A1 17,20-lyase (and delta-16-synthase) activity through physical interaction at defined surface residues, is required for androstenedione and DHEA production in adrenal and gonadal steroidogenesis, and redundantly supports sterol C4-demethylation in cholesterol biosynthesis together with mitochondrial CYB5B; additionally, CYB5A promotes autophagy via the AKT/mTOR/ULK1 pathway in non-steroidogenic contexts such as osteogenic differentiation and cancer cell biology."},"narrative":{"mechanistic_narrative":"CYB5A encodes microsomal cytochrome b5, an electron-transfer hemoprotein that functions principally as an obligate cofactor for CYP17A1 17,20-lyase activity in steroidogenesis [PMID:25890314, PMID:32051920]. CYB5A physically interacts with CYP17A1 through defined surface residues (including N62S, N21K, L28V, R52M), and this interaction selectively stimulates the 17,20-lyase and delta-16-synthase reactions to drive production of DHEA and 16-androstene from pregnenolone [PMID:31509771]. Consistent with this cofactor role, CYB5A is required for adrenal androstenedione synthesis at the zona fasciculata/reticularis border where it is co-expressed with HSD3B2 [PMID:21185375], and its expression and activity quantitatively gate lyase output and androstenone (16-androstene) biosynthesis [PMID:25890314, PMID:16104384, PMID:25516134]. Homozygous loss-of-function in CYB5A causes isolated 17,20-lyase deficiency together with methemoglobinemia in humans, establishing the in vivo requirement, while steroid metabolomics shows CYB5A dependence is developmentally staged and that an independent lyase activity handles cortisol side-chain cleavage [PMID:32051920, PMID:33626548]. Beyond steroidogenesis, CYB5A acts redundantly with mitochondrial CYB5B to support the sterol-C4 oxidation/demethylation step of cholesterol biosynthesis, with either paralog sufficient to sustain this reaction [PMID:39489939]. CYB5A additionally promotes autophagy via the AKT/mTOR/ULK1 axis in osteogenic differentiation [PMID:40246926].","teleology":[{"year":2005,"claim":"Established that CYB5A enzymatic activity itself, not merely its abundance, causally drives 16-androstene biosynthesis, linking a regulatory variant to a steroid phenotype.","evidence":"Functional CYB5A activity assay across porcine 5'UTR genotypes with androstenone measurement in testis samples","pmids":["16104384"],"confidence":"Medium","gaps":["Did not resolve the molecular interaction with CYP17A1","Associative link between activity and androstenone in tissue, not reconstituted"]},{"year":2010,"claim":"Defined the cellular basis for adrenal androgen synthesis by showing CYB5A is required for androstenedione production and is co-localized with HSD3B2 at the ZF/ZR border.","evidence":"siRNA knockdown in H295R adrenal cells with androstenedione readout plus co-immunolocalization in human adrenal tissue","pmids":["21185375"],"confidence":"Medium","gaps":["Did not establish direct physical interaction with CYP17A1","Mechanism of CYB5A action on the lyase reaction not addressed"]},{"year":2014,"claim":"Identified promoter SNPs that alter transcription factor binding and CYB5A expression, explaining how regulatory variation translates into differential steroid output.","evidence":"Luciferase reporter assays, EMSA, and qPCR of liver tissue with in silico TF prediction in pigs","pmids":["25516134"],"confidence":"Medium","gaps":["Predicted MAZ binding site not confirmed by direct factor identification","Connection to steroidogenic tissue regulation inferred from liver expression"]},{"year":2014,"claim":"First implicated CYB5A in a non-steroidogenic role, suppressing oncogenic phenotypes through autophagy induction in pancreatic cancer cells.","evidence":"Loss-of-function in vitro and in vivo studies with autophagy readouts and TRAF6 pathway analysis","pmids":["24448000"],"confidence":"Low","gaps":["Limited methodological detail; no orthogonal mechanistic validation described","Direct link between cytochrome b5 electron-transfer function and autophagy not established","Role of TRAF6 not mechanistically resolved"]},{"year":2015,"claim":"Quantitatively established CYB5A as a dose-dependent augmenter of CYP17A1 17,20-lyase activity by linking an expression-increasing SNP to elevated lyase output.","evidence":"Radiolabeled steroid conversion assay in synovial fibroblasts with qRT-PCR and immunohistochemistry","pmids":["25890314"],"confidence":"Medium","gaps":["Correlative between mRNA level and lyase activity","Did not map the interaction interface with CYP17A1"]},{"year":2019,"claim":"Resolved the molecular mechanism by mapping specific CYB5A surface residues that mediate physical interaction with CYP17A1 to stimulate the 17,20-lyase and delta-16-synthase reactions.","evidence":"Site-directed mutagenesis of CYB5A/CYP17A1 reconstituted with POR and CYB5R3 in HEK293, radiolabeled pregnenolone conversion by HPLC","pmids":["31509771"],"confidence":"High","gaps":["No high-resolution structure of the CYB5A-CYP17A1 complex","Electron transfer versus allosteric contribution to lyase stimulation not fully separated"]},{"year":2019,"claim":"Demonstrated the in vivo requirement for CYB5A in human steroidogenesis, showing loss-of-function causes isolated 17,20-lyase deficiency with methemoglobinemia.","evidence":"Clinical case with genetic sequencing, hormonal studies, and methemoglobin measurement","pmids":["32051920"],"confidence":"Medium","gaps":["Single case","Did not dissect tissue-specific contributions or developmental dependence"]},{"year":2021,"claim":"Refined the in vivo model by showing CYB5A dependence of DHEA synthesis is developmentally staged and that a separate, CYB5A-independent lyase activity handles cortisol side-chain cleavage.","evidence":"Urine steroid metabolomics across age groups in CYB5A-deficient patients with gonadotropin stimulation testing","pmids":["33626548"],"confidence":"Medium","gaps":["Small case series","Identity of the CYB5A-independent lyase activity not determined","Mechanism of reduced neonatal DHEAS dependence unresolved"]},{"year":2024,"claim":"Defined a second metabolic role by showing CYB5A and mitochondrial CYB5B act redundantly to support the sterol-C4 demethylation step of cholesterol biosynthesis.","evidence":"CRISPR knockout of CYB5B in HeLa, liver-specific Cyb5b knockout mice with Cyb5a shRNA, sterol profiling and SREBP/PPARgamma analysis","pmids":["39489939"],"confidence":"High","gaps":["Relative contribution of CYB5A versus CYB5B in steroidogenic tissues not addressed","Direct enzyme target of electron transfer in C4-demethylation not specified"]},{"year":2025,"claim":"Extended the autophagy role to a defined signaling axis, showing CYB5A promotes osteogenic differentiation by stimulating autophagy through AKT/mTOR/ULK1.","evidence":"Overexpression and siRNA in MC3T3-E1 cells with LC3/P62/phospho-mTOR/ULK1 Western blots and pharmacological autophagy modulation","pmids":["40246926"],"confidence":"Medium","gaps":["How the cytochrome b5 electron-transfer function connects to AKT/mTOR signaling is unknown","Direct molecular partners upstream of AKT not identified","Single cell-line system"]},{"year":null,"claim":"How CYB5A's canonical electron-transfer biochemistry mechanistically links to its autophagy-promoting activity, and what governs its tissue- and developmental-stage-specific deployment across steroidogenesis and cholesterol biosynthesis, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of the CYB5A-CYP17A1 complex","Mechanistic bridge between electron transfer and AKT/mTOR/ULK1 signaling undefined","Identity of the CYB5A-independent cortisol lyase activity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[2,3,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,3]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,3,4]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[8]}],"complexes":[],"partners":["CYP17A1","HSD3B2","CYB5B","POR","CYB5R3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P00167","full_name":"Cytochrome b5","aliases":["Microsomal cytochrome b5 type A","MCB5"],"length_aa":134,"mass_kda":15.3,"function":"Cytochrome b5 is a membrane-bound hemoprotein functioning as an electron carrier for several membrane-bound oxygenases","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P00167/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CYB5A","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"RTN4","stoichiometry":4.0},{"gene":"BCAP31","stoichiometry":0.2},{"gene":"CANX","stoichiometry":0.2},{"gene":"COPB2","stoichiometry":0.2},{"gene":"DDOST","stoichiometry":0.2},{"gene":"EMC4","stoichiometry":0.2},{"gene":"OST4","stoichiometry":0.2},{"gene":"RER1","stoichiometry":0.2},{"gene":"RPN1","stoichiometry":0.2},{"gene":"RPN2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CYB5A","total_profiled":1310},"omim":[{"mim_id":"615341","title":"CYTOCHROME P450, FAMILY 4, SUBFAMILY A, POLYPEPTIDE 22; CYP4A22","url":"https://www.omim.org/entry/615341"},{"mim_id":"613218","title":"CYTOCHROME b5, TYPE A (MICROSOMAL); CYB5A","url":"https://www.omim.org/entry/613218"},{"mim_id":"613213","title":"CYTOCHROME b5 REDUCTASE 3; CYB5R3","url":"https://www.omim.org/entry/613213"},{"mim_id":"611964","title":"CYTOCHROME b5, TYPE B (OUTER MITOCHONDRIAL MEMBRANE); CYB5B","url":"https://www.omim.org/entry/611964"},{"mim_id":"608343","title":"CYTOCHROME b5 REDUCTASE 4; CYB5R4","url":"https://www.omim.org/entry/608343"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Vesicles","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"kidney","ntpm":828.0},{"tissue":"liver","ntpm":2306.7}],"url":"https://www.proteinatlas.org/search/CYB5A"},"hgnc":{"alias_symbol":["MCB5"],"prev_symbol":["CYB5"]},"alphafold":{"accession":"P00167","domains":[{"cath_id":"3.10.120.10","chopping":"10-97","consensus_level":"high","plddt":89.1457,"start":10,"end":97}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P00167","model_url":"https://alphafold.ebi.ac.uk/files/AF-P00167-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P00167-F1-predicted_aligned_error_v6.png","plddt_mean":80.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CYB5A","jax_strain_url":"https://www.jax.org/strain/search?query=CYB5A"},"sequence":{"accession":"P00167","fasta_url":"https://rest.uniprot.org/uniprotkb/P00167.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P00167/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P00167"}},"corpus_meta":[{"pmid":"21185375","id":"PMC_21185375","title":"Human adrenal cells that express both 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) and cytochrome b5 (CYB5A) contribute to adrenal androstenedione production.","date":"2010","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21185375","citation_count":28,"is_preprint":false},{"pmid":"25890314","id":"PMC_25890314","title":"CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women.","date":"2015","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25890314","citation_count":24,"is_preprint":false},{"pmid":"24832628","id":"PMC_24832628","title":"3βHSD and CYB5A double positive adrenocortical cells during adrenal development/aging.","date":"2014","source":"Endocrine research","url":"https://pubmed.ncbi.nlm.nih.gov/24832628","citation_count":20,"is_preprint":false},{"pmid":"16104384","id":"PMC_16104384","title":"A novel polymorphism in the 5' untranslated region of the porcine cytochrome b5 (CYB5) gene is associated with decreased fat androstenone level.","date":"2005","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/16104384","citation_count":20,"is_preprint":false},{"pmid":"22850190","id":"PMC_22850190","title":"Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.","date":"2012","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/22850190","citation_count":15,"is_preprint":false},{"pmid":"25516134","id":"PMC_25516134","title":"Differential expression of CYB5A in Chinese and European pig breeds due to genetic variations in the promoter region.","date":"2014","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25516134","citation_count":13,"is_preprint":false},{"pmid":"25225034","id":"PMC_25225034","title":"Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.","date":"2014","source":"Cancer causes & control : CCC","url":"https://pubmed.ncbi.nlm.nih.gov/25225034","citation_count":13,"is_preprint":false},{"pmid":"24448000","id":"PMC_24448000","title":"CYB5A and autophagy-mediated cell death in pancreatic cancer.","date":"2014","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/24448000","citation_count":12,"is_preprint":false},{"pmid":"15328107","id":"PMC_15328107","title":"Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity.","date":"2004","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/15328107","citation_count":11,"is_preprint":false},{"pmid":"32051920","id":"PMC_32051920","title":"Isolated 17,20-Lyase Deficiency in a CYB5A Mutated Female With Normal Sexual Development and Fertility.","date":"2019","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/32051920","citation_count":11,"is_preprint":false},{"pmid":"39489939","id":"PMC_39489939","title":"Defects in CYB5A and CYB5B impact sterol-C4 oxidation in cholesterol biosynthesis and demonstrate regulatory roles of dimethyl sterols.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39489939","citation_count":8,"is_preprint":false},{"pmid":"31509771","id":"PMC_31509771","title":"Effect of mutations in porcine CYB5A and CYP17A1 on the metabolism of pregnenolone.","date":"2019","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31509771","citation_count":8,"is_preprint":false},{"pmid":"22816446","id":"PMC_22816446","title":"Evaluation of polymorphisms in the sulfonamide detoxification genes CYB5A and CYB5R3 in dogs with sulfonamide hypersensitivity.","date":"2012","source":"Journal of veterinary internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22816446","citation_count":7,"is_preprint":false},{"pmid":"35043601","id":"PMC_35043601","title":"Functional variants in cytochrome b5 type A (CYB5A) are enriched in Southwest American Indian individuals and associate with obesity.","date":"2022","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/35043601","citation_count":6,"is_preprint":false},{"pmid":"22445012","id":"PMC_22445012","title":"Effect of polymorphism in the porcine cytochrome b5 ( CYB5A) gene on androstenone and skatole concentrations and sexual development in Swedish pig populations.","date":"2008","source":"Animal : an international journal of animal bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/22445012","citation_count":6,"is_preprint":false},{"pmid":"27136898","id":"PMC_27136898","title":"2,3,7,8 Tetrachlorodibenzo-p-dioxin-induced RNA abundance changes identify Ackr3, Col18a1, Cyb5a and Glud1 as candidate mediators of toxicity.","date":"2016","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/27136898","citation_count":6,"is_preprint":false},{"pmid":"40246926","id":"PMC_40246926","title":"CYB5A promotes osteogenic differentiation of MC3T3-E1 cells through autophagy mediated by the AKT/mTOR/ULK1 signaling pathway.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40246926","citation_count":5,"is_preprint":false},{"pmid":"33626548","id":"PMC_33626548","title":"Isolated 17, 20 Lyase Deficiency Secondary to a Novel CYB5A Variant: Comparison of Steroid Metabolomic Findings with Published Cases Provides Diagnostic Guidelines and Greater Insight into Its Biological Role.","date":"2021","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/33626548","citation_count":4,"is_preprint":false},{"pmid":"34160668","id":"PMC_34160668","title":"Lack of association between CYB5A gene rs1790834 polymorphism and the response to leflunomide in women with rheumatoid arthritis.","date":"2021","source":"European journal of clinical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34160668","citation_count":3,"is_preprint":false},{"pmid":"40123165","id":"PMC_40123165","title":"Two families, two pathways: a case series of 46, XY DSD with 17α-hydroxylase deficiency and isolated 17,20-lyase deficiency due to novel CYB5A variant.","date":"2025","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/40123165","citation_count":2,"is_preprint":false},{"pmid":"37289314","id":"PMC_37289314","title":"The association between CYB5A gene rs1790834 polymorphism and clinical improvement after 6 months of leflunomide treatment in women with rheumatoid arthritis.","date":"2023","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/37289314","citation_count":1,"is_preprint":false},{"pmid":"35436854","id":"PMC_35436854","title":"An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse.","date":"2022","source":"BMC genomic data","url":"https://pubmed.ncbi.nlm.nih.gov/35436854","citation_count":1,"is_preprint":false},{"pmid":"27524697","id":"PMC_27524697","title":"Development of CYB5-fusion monitoring system for efficient periplasmic expression of multimeric proteins in Escherichia coli.","date":"2016","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/27524697","citation_count":1,"is_preprint":false},{"pmid":"41453937","id":"PMC_41453937","title":"Micro RNA miR-726-3p targets CYB5A in Hen ovaries to modulate granulosa cell proliferation and differentiation.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41453937","citation_count":0,"is_preprint":false},{"pmid":"41052660","id":"PMC_41052660","title":"Haplotype-based association of CYB5A gene polymorphisms (rs1790834 and rs1790858) with polycystic ovary syndrome in a south Indian cohort.","date":"2025","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/41052660","citation_count":0,"is_preprint":false},{"pmid":"41891695","id":"PMC_41891695","title":"The azole-resistance phenotype of a Nakaseomyces glabratus clinical strain encoding a wild-type PDR1 allele involves the efflux pumps Aus1 and Pdh1 and Cyb5, an alternative reductase required for ergosterol biosynthesis.","date":"2026","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/41891695","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16395,"output_tokens":2667,"usd":0.044595,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9849,"output_tokens":3404,"usd":0.067172,"stage2_stop_reason":"end_turn"},"total_usd":0.111767,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"CYB5A is required for androstenedione production in human adrenal cells: siRNA knockdown of CYB5A in H295R adrenal cells significantly inhibited androstenedione production, and co-expression of CYB5A with HSD3B2 was identified at the ZF/ZR border as the cellular basis for adrenal androstenedione synthesis.\",\n      \"method\": \"siRNA knockdown in H295R cells with androstenedione measurement; co-immunolocalization of HSD3B2 and CYB5A in human adrenal tissue\",\n      \"journal\": \"The Journal of steroid biochemistry and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean siRNA knockdown with defined steroid phenotype plus orthogonal immunolocalization, single lab\",\n      \"pmids\": [\"21185375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A CYB5A intronic SNP (rs1790834) doubles CYB5A mRNA expression and results in 2–3-fold activation of steroid 17,20-lyase activity, establishing CYB5A as a critical cofactor that augments CYP17A1 17,20-lyase activity in human steroidogenesis.\",\n      \"method\": \"Radiolabeled steroid conversion assay in synovial fibroblasts; quantitative RT-PCR; immunohistochemistry of synovial tissue\",\n      \"journal\": \"Arthritis research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional steroid conversion assay with radiolabeled substrate plus mRNA quantification, single lab\",\n      \"pmids\": [\"25890314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A SNP in the 5' UTR of porcine CYB5A (G→T at position −8 of ATG) reduces CYB5A enzymatic activity and is associated with lower fat androstenone levels, demonstrating that CYB5A activity directly drives 16-androstene (androstenone) biosynthesis.\",\n      \"method\": \"Functional analysis of CYB5A enzyme activity in individuals of different genotypes; androstenone measurement in 229 testis samples\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzyme activity measurement linked to genotype with large sample size, single lab\",\n      \"pmids\": [\"16104384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Specific surface residues of porcine CYB5A mediate its physical interaction with CYP17A1 to stimulate 17,20-lyase and delta-16-synthase reactions: mutations at CYB5A surface residues (including N62S, N21K, L28V, R52M) altered production of DHEA and 16-androstene (16A) from pregnenolone, and the N62S mutation increased both 16A and DHEA production when combined with wild-type CYP17A1.\",\n      \"method\": \"Site-directed mutagenesis of CYB5A and CYP17A1; co-expression with POR and CYB5R3 in HEK293 cells; radiolabeled pregnenolone conversion measured by HPLC\",\n      \"journal\": \"The Journal of steroid biochemistry and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in cell-based system with mutagenesis and quantitative metabolite profiling; multiple residues tested with orthogonal outcomes\",\n      \"pmids\": [\"31509771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CYB5A and mitochondrial CYB5B redundantly support sterol C4-demethylation in cholesterol biosynthesis: knockout of CYB5B alone blocks cholesterol biosynthesis at the sterol-C4 oxidation step in HeLa cells (accumulating T-MAS and dihydro-T-MAS), whereas liver-specific Cyb5b knockout mice are rescued by residual Cyb5a; combined knockdown of both in liver causes marked T-MAS/dihydro-T-MAS accumulation, demonstrating that either CYB5A or CYB5B is sufficient for sterol C4-demethylation.\",\n      \"method\": \"CRISPR knockout of CYB5B in HeLa cells; liver-specific Cyb5b knockout mice with shRNA knockdown of Cyb5a; sterol profiling; SREBP/PPARγ pathway analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro and in vivo knockouts with defined sterol metabolite readouts, multiple genetic combinations, orthogonal pathway analyses\",\n      \"pmids\": [\"39489939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Loss-of-function mutations in CYB5A cause isolated 17,20-lyase deficiency in humans: a homozygous nonsense mutation (p.Tyr35Ter) in CYB5A results in methemoglobinemia and biochemically confirmed isolated 17,20-lyase deficiency, demonstrating that CYB5A is required for CYP17A1 17,20-lyase activity in vivo.\",\n      \"method\": \"Clinical case with genetic sequencing; hormonal studies confirming isolated 17,20-lyase deficiency; methemoglobin measurement\",\n      \"journal\": \"Journal of the Endocrine Society\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human loss-of-function variant with defined biochemical phenotype; single case but consistent with genetic mechanism\",\n      \"pmids\": [\"32051920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Steroid metabolomics in patients with novel CYB5A loss-of-function variants reveals that CYB5A is required for DHEA synthesis postnatally but that neonatal DHEAS production is less dependent on CYB5A, and that a separate lyase activity independent of CYB5A handles cortisol side-chain cleavage.\",\n      \"method\": \"Urine steroid metabolomics (mass spectrometry) across age groups in CYB5A-deficient patients; gonadotropin stimulation testing\",\n      \"journal\": \"Hormone research in paediatrics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human loss-of-function with quantitative steroid metabolomics, multiple time points, but small case series\",\n      \"pmids\": [\"33626548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CYB5A inhibits oncogenic phenotypes in pancreatic cancer cells through induction of autophagy, and its inhibitory activity involves downstream pathways including TRAF6.\",\n      \"method\": \"In vitro and in vivo studies (loss-of-function) with autophagy readouts; pathway analysis involving TRAF6\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — abstract describes in vitro/in vivo results but provides limited methodological detail; single lab, no orthogonal mechanistic validation described\",\n      \"pmids\": [\"24448000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CYB5A promotes osteogenic differentiation of MC3T3-E1 cells by stimulating autophagy through the AKT/mTOR/ULK1 signaling pathway: CYB5A overexpression increased LC3-II/LC3-I ratio, decreased P62, activated ULK1, and reduced mTOR phosphorylation; autophagy inhibitors and activators confirmed pathway mediation.\",\n      \"method\": \"Overexpression and siRNA knockdown in MC3T3-E1 cells; Western blotting for LC3-II/LC3-I, P62, phospho-mTOR, ULK1; autophagy inhibitor/activator pharmacological validation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with multiple pathway readouts and pharmacological confirmation, single lab\",\n      \"pmids\": [\"40246926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SNPs in the porcine CYB5A promoter region affect transcription factor binding and CYB5A expression levels: haplotype B (containing specific SNPs) showed higher reporter activity in cell transfection assays, and EMSA demonstrated that the SNP at position 165901767 affects stable binding of transcription factors (including predicted MAZ binding site) to the CYB5A promoter, translating into differential androstenone accumulation between Chinese and European pig breeds.\",\n      \"method\": \"Luciferase reporter assay; electrophoretic mobility shift assay (EMSA); quantitative PCR of liver tissues; in silico transcription factor prediction\",\n      \"journal\": \"Animal genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter assay with orthogonal in vivo expression data, single lab\",\n      \"pmids\": [\"25516134\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CYB5A encodes microsomal cytochrome b5, a hemoprotein electron transfer cofactor that directly augments CYP17A1 17,20-lyase (and delta-16-synthase) activity through physical interaction at defined surface residues, is required for androstenedione and DHEA production in adrenal and gonadal steroidogenesis, and redundantly supports sterol C4-demethylation in cholesterol biosynthesis together with mitochondrial CYB5B; additionally, CYB5A promotes autophagy via the AKT/mTOR/ULK1 pathway in non-steroidogenic contexts such as osteogenic differentiation and cancer cell biology.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CYB5A encodes microsomal cytochrome b5, an electron-transfer hemoprotein that functions principally as an obligate cofactor for CYP17A1 17,20-lyase activity in steroidogenesis [#1, #5]. CYB5A physically interacts with CYP17A1 through defined surface residues (including N62S, N21K, L28V, R52M), and this interaction selectively stimulates the 17,20-lyase and delta-16-synthase reactions to drive production of DHEA and 16-androstene from pregnenolone [#3]. Consistent with this cofactor role, CYB5A is required for adrenal androstenedione synthesis at the zona fasciculata/reticularis border where it is co-expressed with HSD3B2 [#0], and its expression and activity quantitatively gate lyase output and androstenone (16-androstene) biosynthesis [#1, #2, #9]. Homozygous loss-of-function in CYB5A causes isolated 17,20-lyase deficiency together with methemoglobinemia in humans, establishing the in vivo requirement, while steroid metabolomics shows CYB5A dependence is developmentally staged and that an independent lyase activity handles cortisol side-chain cleavage [#5, #6]. Beyond steroidogenesis, CYB5A acts redundantly with mitochondrial CYB5B to support the sterol-C4 oxidation/demethylation step of cholesterol biosynthesis, with either paralog sufficient to sustain this reaction [#4]. CYB5A additionally promotes autophagy via the AKT/mTOR/ULK1 axis in osteogenic differentiation [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established that CYB5A enzymatic activity itself, not merely its abundance, causally drives 16-androstene biosynthesis, linking a regulatory variant to a steroid phenotype.\",\n      \"evidence\": \"Functional CYB5A activity assay across porcine 5'UTR genotypes with androstenone measurement in testis samples\",\n      \"pmids\": [\"16104384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not resolve the molecular interaction with CYP17A1\", \"Associative link between activity and androstenone in tissue, not reconstituted\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined the cellular basis for adrenal androgen synthesis by showing CYB5A is required for androstenedione production and is co-localized with HSD3B2 at the ZF/ZR border.\",\n      \"evidence\": \"siRNA knockdown in H295R adrenal cells with androstenedione readout plus co-immunolocalization in human adrenal tissue\",\n      \"pmids\": [\"21185375\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish direct physical interaction with CYP17A1\", \"Mechanism of CYB5A action on the lyase reaction not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified promoter SNPs that alter transcription factor binding and CYB5A expression, explaining how regulatory variation translates into differential steroid output.\",\n      \"evidence\": \"Luciferase reporter assays, EMSA, and qPCR of liver tissue with in silico TF prediction in pigs\",\n      \"pmids\": [\"25516134\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Predicted MAZ binding site not confirmed by direct factor identification\", \"Connection to steroidogenic tissue regulation inferred from liver expression\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"First implicated CYB5A in a non-steroidogenic role, suppressing oncogenic phenotypes through autophagy induction in pancreatic cancer cells.\",\n      \"evidence\": \"Loss-of-function in vitro and in vivo studies with autophagy readouts and TRAF6 pathway analysis\",\n      \"pmids\": [\"24448000\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Limited methodological detail; no orthogonal mechanistic validation described\", \"Direct link between cytochrome b5 electron-transfer function and autophagy not established\", \"Role of TRAF6 not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Quantitatively established CYB5A as a dose-dependent augmenter of CYP17A1 17,20-lyase activity by linking an expression-increasing SNP to elevated lyase output.\",\n      \"evidence\": \"Radiolabeled steroid conversion assay in synovial fibroblasts with qRT-PCR and immunohistochemistry\",\n      \"pmids\": [\"25890314\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative between mRNA level and lyase activity\", \"Did not map the interaction interface with CYP17A1\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved the molecular mechanism by mapping specific CYB5A surface residues that mediate physical interaction with CYP17A1 to stimulate the 17,20-lyase and delta-16-synthase reactions.\",\n      \"evidence\": \"Site-directed mutagenesis of CYB5A/CYP17A1 reconstituted with POR and CYB5R3 in HEK293, radiolabeled pregnenolone conversion by HPLC\",\n      \"pmids\": [\"31509771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the CYB5A-CYP17A1 complex\", \"Electron transfer versus allosteric contribution to lyase stimulation not fully separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated the in vivo requirement for CYB5A in human steroidogenesis, showing loss-of-function causes isolated 17,20-lyase deficiency with methemoglobinemia.\",\n      \"evidence\": \"Clinical case with genetic sequencing, hormonal studies, and methemoglobin measurement\",\n      \"pmids\": [\"32051920\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case\", \"Did not dissect tissue-specific contributions or developmental dependence\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Refined the in vivo model by showing CYB5A dependence of DHEA synthesis is developmentally staged and that a separate, CYB5A-independent lyase activity handles cortisol side-chain cleavage.\",\n      \"evidence\": \"Urine steroid metabolomics across age groups in CYB5A-deficient patients with gonadotropin stimulation testing\",\n      \"pmids\": [\"33626548\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Small case series\", \"Identity of the CYB5A-independent lyase activity not determined\", \"Mechanism of reduced neonatal DHEAS dependence unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a second metabolic role by showing CYB5A and mitochondrial CYB5B act redundantly to support the sterol-C4 demethylation step of cholesterol biosynthesis.\",\n      \"evidence\": \"CRISPR knockout of CYB5B in HeLa, liver-specific Cyb5b knockout mice with Cyb5a shRNA, sterol profiling and SREBP/PPARgamma analysis\",\n      \"pmids\": [\"39489939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of CYB5A versus CYB5B in steroidogenic tissues not addressed\", \"Direct enzyme target of electron transfer in C4-demethylation not specified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended the autophagy role to a defined signaling axis, showing CYB5A promotes osteogenic differentiation by stimulating autophagy through AKT/mTOR/ULK1.\",\n      \"evidence\": \"Overexpression and siRNA in MC3T3-E1 cells with LC3/P62/phospho-mTOR/ULK1 Western blots and pharmacological autophagy modulation\",\n      \"pmids\": [\"40246926\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How the cytochrome b5 electron-transfer function connects to AKT/mTOR signaling is unknown\", \"Direct molecular partners upstream of AKT not identified\", \"Single cell-line system\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CYB5A's canonical electron-transfer biochemistry mechanistically links to its autophagy-promoting activity, and what governs its tissue- and developmental-stage-specific deployment across steroidogenesis and cholesterol biosynthesis, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of the CYB5A-CYP17A1 complex\", \"Mechanistic bridge between electron transfer and AKT/mTOR/ULK1 signaling undefined\", \"Identity of the CYB5A-independent cortisol lyase activity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [2, 3, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CYP17A1\", \"HSD3B2\", \"CYB5B\", \"POR\", \"CYB5R3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}